MENA PV Landscape – Key Updates & Inspection Trends

Timely insights on the evolving Pharmacovigilance landscape in the MENA region.

In this episode of Biomapas Insights, Albert Bekfi, Head of Global Pharmacovigilance Operations at Biomapas, speaks with Mina Awad, a GxP Auditor, Inspector, and PV expert with over 17 years in the pharmaceutical industry. Based in the United Arab Emirates (UAE) and originally from Egypt, Mina shares timely insights on the evolving Pharmacovigilance landscape in the Middle East and North Africa (MENA) region.

They will discuss:

  • 2025 PV updates in the UAE, Kuwait, and Lebanon
  • UAE GVP changes and the role of the new Emirati Drug Establishment (EDE)
  • Increasing activity from local Health Authorities
  • Inspection trends across UAE, Saudi Arabia, and Egypt
  • Common findings: PV agreements and QPPV qualifications
  • Managing local distributors and business partners
Global Literature Review: Ensuring Safety through Robust Processes

Global Literature Review: Ensuring Safety through Robust Processes

In pharmacovigilance, timely identification of safety signals is essential to protecting patients – which is why our Global Literature Review (GLR) process provides a systematic and reliable way to capture, analyze, and document safety data from trusted scientific...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information